Concepedia

Thierry Conroy

TC

Statistics

Publications

89

Citations

17.3K

H-Index

47

Active since

1991

Affiliations

Institut de Cancérologie de Lorraine(Current)

Université de Lorraine

Délégation Centre-Est

Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est

Inserm

Thierry Conroy is an author at Institut de Cancérologie de Lorraine specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

1991–2025

89

Publications

89

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

, , +14

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Marc Ychou, Valérie Boige, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2011 · 2.1K citations · Full text

, , +9

Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

Jean‐Pierre Gérard, Thierry Conroy, Franck Bonnetain et al. · Journal of Clinical Oncology · 2006 · 1.7K citations

, , +15

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Michel Ducreux, Caroline Caramella, Antoine Hollebecque et al. · Annals of Oncology · 2015 · 1.3K citations · Full text

, , +12

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne et al. · The Lancet Oncology · 2021 · 1.3K citations

, , +17

1–5 of 89